BCPPF
BCE INC
$11.00
0.00%
No data for this timeframe.
Vol
SEC Reports6
Recent Activity
Jun 5, 2026
SEC
BCE Inc. (BCPPF) filed a 6-K reporting that its subsidiary Bell Canada priced and closed a US$650,000,000 offering of 5.
6-K — Impact 4/10
May 28, 2026
SEC
Bell Canada announced two concurrent debt offerings: C$1.6 billion in MTN Debentures (two series) and US$650 million in
6-K — Impact 4/10
May 7, 2026
SEC
BCE reported Q1 2026 revenue growth of 4.0% to $6,168 million, driven by the Ziply Fiber acquisition, but net earnings f
6-K — Impact 5/10
Analyst Ratings
1Strong Buy
9Buy
9Hold
3Sell
0Strong Sell
Latest Reports
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
6 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 1 mixed, 5 neutral. Avg impact: 3.7/10.
NEUTRAL
6-K
4/10
BCE Inc. (BCPPF) filed a 6-K reporting that its subsidiary Bell Canada priced and closed a US$650,00
Jun 5, 2026
NEUTRAL
6-K
4/10
Bell Canada announced two concurrent debt offerings: C$1.6 billion in MTN Debentures (two series) an
May 28, 2026
MIXED
6-K
5/10
BCE reported Q1 2026 revenue growth of 4.0% to $6,168 million, driven by the Ziply Fiber acquisition
May 7, 2026
NEUTRAL
6-K
3/10
BCE Inc. announced the results of conversions between its Series AG and AH preferred shares, with 12
Apr 22, 2026
NEUTRAL
EFFECT
3/10
BCE Inc and its subsidiary Bell Canada have an effective registration statement (Form F-10) as of Ap
Apr 8, 2026
NEUTRAL
6-K
3/10
BCE Inc. subsidiary Bell Canada renewed its Medium Term Notes (MTN) program, allowing it to issue de
Apr 7, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 45% buy across 22 analysts — 1 strong buy, 9 buy, 9 hold, 3 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $6.3B | 2.8% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $6.1B | 1.5% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $25.0B | 2.4% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $25.5B | 1.8% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 1 | 9 | 9 | 3 | 0 | 45% | |
| May 1, 2026 | 1 | 9 | 9 | 3 | 0 | 45% | |
| Apr 1, 2026 | 1 | 9 | 8 | 3 | 0 | 48% | |
| Mar 1, 2026 | 1 | 9 | 8 | 3 | 0 | 48% | |
| Feb 1, 2026 | 1 | 10 | 8 | 3 | 0 | 50% | |
| Jan 1, 2026 | 1 | 10 | 7 | 4 | 0 | 50% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.